ArticleBMC musculoskeletal disorders2025
Mechanisms of pyroptosis in modulating osteoblast function under simulated microgravity.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep space environment empowering drug design and development.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025Review
- NLRP3 Inflammasome-Mediated Pyroptosis in Osteoporosis: Osteoimmune Mechanisms and Therapeutic Targeting.Journal of cellular and molecular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBone mass loss resulting from mechanical unloading in a microgravity environment constitutes a primary impediment to the advancement of space exploration for astronauts. However, the underlying mechanism remains unclear. In this study, we primarily investigated the impact of pyroptosis on osteoblasts under simulated microgravity and its influence on osteoblast functionality.
methodsA rotary cell culture system was employed to establish a simulated microgravity environment. The proliferation of osteoblasts was assessed by cell counting kit-8 (CCK-8) assay. Lactate dehydrogenase (LDH) Release Assay Kit was used to measure cell necrosis. Osteoblast differentiation and mineralization were evaluated using an ALP kit and alizarin red staining. Fluorescence Hoechst/PI double staining and scanning electron microscopy (SEM) were used to detect pyroptosis, and a caspase-1 kit measured caspase-1 activity. The expression of NLRP3, caspase-1, GSDMD, IL-1β, IL-18, OCN, and COL-I was analyzed by qPCR and Western blot. Additionally, ELISA was used to quantify the release of IL-1β and IL-18.
resultsThe PI fluorescence in osteoblasts exhibited significant enhancement under simulated microgravity conditions, accompanied by increased membrane pore formation, decreased cell proliferation, and elevated LDH release. Moreover, the expression levels of NLRP3, caspase-1, GSDMD, IL-1β, and IL-18 were upregulated while caspase-1 activity was increased. Treatment with MCC950 and VX-765 effectively attenuated pyroptosis levels as well as caspase-1 activity while reducing the expression of NLRP3, GSDMD, IL-1β, and IL-18. Notably, this treatment significantly enhanced the expression of OCN and COL-I.
conclusionUnder simulated microgravity conditions, pyroptosis occurs in osteoblasts and alters their osteogenic differentiation function. Pyroptosis modulates the functionality of osteoblasts and contributes to the mechanical response process, potentially serving as one of the mechanisms underlying mechanical-regulated osteoblast function in a microgravity environment. This finding may offer a novel approach for addressing bone tissue damage and repair under extreme mechanical conditions. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.